Coya Therapeutics (COYA) Market Capitalization (2022 - 2026)

Coya Therapeutics has disclosed Market Capitalization across 5 years of filings, most recently posting $137.2 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 42.7% year-over-year to $137.2 million; the TTM figure through Jun 2026 stood at $137.2 million (up 42.7% YoY), while the FY2025 annual figure was $97.0 million, up 1.36% from the prior year.
• Market Capitalization came in at $137.2 million for Q2 2026 at Coya Therapeutics, up from $92.4 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $145.0 million in Q1 2024 to a low of $12.3 million in Q4 2022.
• Average Market Capitalization over 5 years is $84.2 million, with a median of $95.4 million recorded in 2025.
• Year-over-year, Market Capitalization surged 513.44% in 2023 and decreased 25.35% in 2025.
• Over 5 years, Market Capitalization stood at $12.3 million in 2022, then surged by 513.44% to $75.3 million in 2023, then gained by 27.11% to $95.7 million in 2024, then rose by 1.36% to $97.0 million in 2025, then jumped by 41.42% to $137.2 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $137.2 million in Q2 2026, $92.4 million in Q1 2026, and $97.0 million in Q4 2025.